Early discontinuation of tamoxifen: A lesson for oncologists [3]

Matthew P. Goetz; James Ingle

doi:10.1002/cncr.23064

Early discontinuation of tamoxifen: A lesson for oncologists [3]

Matthew P. Goetz, James Ingle

Medical Oncology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	2595
Number of pages	1
Journal	Cancer
Volume	110
Issue number	11
DOIs	https://doi.org/10.1002/cncr.23064
State	Published - Dec 1 2007

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.23064

Cite this

@article{2468847914c5427eb89e2655704712f7,

title = "Early discontinuation of tamoxifen: A lesson for oncologists [3]",

author = "Goetz, {Matthew P.} and James Ingle",

year = "2007",

month = dec,

day = "1",

doi = "10.1002/cncr.23064",

language = "English (US)",

volume = "110",

pages = "2595",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Early discontinuation of tamoxifen

T2 - A lesson for oncologists [3]

AU - Goetz, Matthew P.

AU - Ingle, James

PY - 2007/12/1

Y1 - 2007/12/1

UR - http://www.scopus.com/inward/record.url?scp=36448966374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36448966374&partnerID=8YFLogxK

U2 - 10.1002/cncr.23064

DO - 10.1002/cncr.23064

M3 - Letter

C2 - 17896782

AN - SCOPUS:36448966374

SN - 0008-543X

VL - 110

SP - 2595

JO - Cancer

JF - Cancer

IS - 11

ER -

Early discontinuation of tamoxifen: A lesson for oncologists [3]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this